Devon Cimino

The World Health Organization describes new recommended treatments for COVID-19 in the 11th update to their living guideline.

Researchers described the effects of oral tecovirimat treatment in 2 men with monkeypox virus-associated severe proctitis.

Investigators collected specimens from the residence of 2 individuals with confirmed monkeypox infection to assess the potential for indirect transmission of monkeypox virus in household environments.

A State Disaster Emergency was declared in New York due to evidence of circulating poliovirus.

Researchers assessed the rate of COVID-19 reinfection during the Omicron wave among individuals in Iceland.

The World Health Organization’s emergency committee met to discuss the multi-country outbreak of monkeypox.

Researchers evaluated the effect of adjuvant colchicine with standard therapy among patients with moderate and severe COVID-19 infection.

In this ninth update to the living guideline on COVID-19 therapeutics, the World Health Organization evaluates the use of nirmatrelvir/ritonavir for nonsevere COVID-19 and revises prior recommendations regarding the use of remdesivir.

Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.